Skip to main content

Table 1 Age, menstrual phase data and hormonal contraception (HC) formulation

From: Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank

Sequencing ID Age Menstrual day HC HC type F or L Estradiol pg/mL Progesterone ng/mL LH milliunits/mL
Normal_1 37 5 no   F 49 0.5 5.7
Normal_2 20 14 yes Tri-Legest Fe - 32 1.5 9.6
Normal_3 30 13 no   F 32 <0.01 3.6
Normal_4 44 19 yes Ortho Tri-Cyclen Lo - 432 0.4 5.1
Normal_5 40 9 no   F 28 0.5 5.6
Normal_6 27 27 yes Nuvaring - N/A N/A N/A
Normal_7 23 29 no   L 71 6.1 3.2
Normal_8 27 25 no   L 82 3.7 4.9
Normal_9 39 4 no   F 198 0.1 N/A
Normal_10 38 26 no   L 131 21.4 3
Normal_11 22 28 yes Necon1-35 - 36 1.1 0.2
Normal_12 45 27 no   L 47 2.9 3.6
Normal_13 19 7 yes Zenchent - 26 0.7 2.4
Normal_14 36 2 no   F 53 0.6 4.4
Normal_15 26 9 no   F 43 0.9 10.3
Normal_16 22 29 no   L 136 12.4 5.3
Normal_17 46 6 no   F 121 0.5 5.6
Normal_18 31 29 yes LoEstrin 24 - 34 1.1 2
Normal_19 29 2 no   F 61 0.6 7.9
Normal_20 21 7 no   F 43 0.3 3.5
HC type
Tri-Legest Fe 1 mg norethindrone acetate and 20 mcg ethinyl estradiol × 1 week; 1 mg norethindrone acetate and 30 mcg ethinyl estradiol × 1 week; 1 mg norethindrone acetate and 35 mcg ethinyl estradiol × 1 week
Ortho Tri-Cyclen Lo 0.180 mg of norgestimate and 0.025 mg ethinyl estradiol × 1 week; 0.215 mg of norgestimate and 0.025 mg ethinyl estradiol × 1 week; 0.250 mg of norgestimate and 0.025 mg of ethinyl estradiol × 1 week
Nuvaring  
Necon1-35 Norethindrone 1 mg, ethinyl estradiol 35 mcg
Zenchent 0.4 mg norethindrone and 0.035 mg ethinyl estradiol
LoEstrin 24 1 mg norethindrone acetate and 20 mcg ethinyl estradiol
  1. Menstrual day was calculated from information provided by the donor on her questionnaire and verified by serum progesterone concentration. F, follicular; L, luteal; LH, luteinizing hormone.